AT292716B - Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon - Google Patents
Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davonInfo
- Publication number
- AT292716B AT292716B AT00204/70A AT20470A AT292716B AT 292716 B AT292716 B AT 292716B AT 00204/70 A AT00204/70 A AT 00204/70A AT 20470 A AT20470 A AT 20470A AT 292716 B AT292716 B AT 292716B
- Authority
- AT
- Austria
- Prior art keywords
- dibenzo
- thiazepine
- oxazepine
- diazepine
- acid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000008569 process Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D267/20—[b, f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electromagnets (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH358267 | 1967-03-13 | ||
| CH410367A CH481133A (de) | 1967-03-22 | 1967-03-22 | Verfahren zur Herstellung basisch substituierter Heterocyclen |
| CH655767A CH484924A (de) | 1967-05-09 | 1967-05-09 | Verfahren zur Herstellung basisch substituierter Heterocyclen |
| CH1011567A CH485752A (de) | 1967-07-14 | 1967-07-14 | Verfahren zur Herstellung basisch substituierter Heterocyclen |
| CH1545367 | 1967-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT292716B true AT292716B (de) | 1971-08-15 |
Family
ID=27509145
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00204/70A AT292716B (de) | 1967-03-13 | 1968-03-05 | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon |
| AT215368A AT292707B (de) | 1967-03-13 | 1968-03-05 | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f]-1,4-oxazepine, Dibenzo[b,f]-1,4-thiazepine und Dibenzo[b,e]-1,4-diazepine, sowie von Säure-Additionssalzen davon |
| AT00206/70A AT292718B (de) | 1967-03-13 | 1968-03-05 | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT215368A AT292707B (de) | 1967-03-13 | 1968-03-05 | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f]-1,4-oxazepine, Dibenzo[b,f]-1,4-thiazepine und Dibenzo[b,e]-1,4-diazepine, sowie von Säure-Additionssalzen davon |
| AT00206/70A AT292718B (de) | 1967-03-13 | 1968-03-05 | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon |
Country Status (9)
| Country | Link |
|---|---|
| AT (3) | AT292716B (cg-RX-API-DMAC10.html) |
| BE (1) | BE712114A (cg-RX-API-DMAC10.html) |
| DE (1) | DE1720007A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR8046M (cg-RX-API-DMAC10.html) |
| GB (1) | GB1216523A (cg-RX-API-DMAC10.html) |
| IL (1) | IL29571A (cg-RX-API-DMAC10.html) |
| NL (1) | NL6803570A (cg-RX-API-DMAC10.html) |
| NO (1) | NO123459B (cg-RX-API-DMAC10.html) |
| SE (1) | SE364277B (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500998D0 (sv) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
| BRPI0417749A (pt) * | 2003-12-22 | 2007-04-10 | Acadia Pharm Inc | composto, método de sintese de composto, bibliotecas combinatórias, composições farmacêuticas e métodos de tratamento de disfunções neuropsiquiátricas |
| WO2007053618A1 (en) * | 2005-10-31 | 2007-05-10 | Acadia Pharmaceuticals Inc. | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| EP1951694A4 (en) * | 2005-11-18 | 2010-09-22 | Astrazeneca Ab | FORMS OF SALTS |
| RU2441867C2 (ru) * | 2010-05-13 | 2012-02-10 | Общество С Ограниченной Ответственностью "Валентек" | ПРОИЗВОДНЫЕ 5H-ДИБЕНЗО[b, e][1, 4]ДИАЗЕПИНА И ИХ ПРИМЕНЕНИЕ |
| WO2013070107A1 (ru) * | 2011-11-09 | 2013-05-16 | Общество С Ограниченной Ответственностью "Валентек" | ПРОИЗВОДНЫЕ 5Н-ДИБЕНЗО[b,е] [1,4]ДИАЗЕПИНA И ИХ ПРИМЕНЕНИЕ |
-
1968
- 1968-03-04 DE DE19681720007 patent/DE1720007A1/de active Pending
- 1968-03-04 IL IL2957168A patent/IL29571A/en unknown
- 1968-03-05 AT AT00204/70A patent/AT292716B/de not_active IP Right Cessation
- 1968-03-05 GB GB00561/68A patent/GB1216523A/en not_active Expired
- 1968-03-05 AT AT215368A patent/AT292707B/de not_active IP Right Cessation
- 1968-03-05 AT AT00206/70A patent/AT292718B/de not_active IP Right Cessation
- 1968-03-08 SE SE03129/68A patent/SE364277B/xx unknown
- 1968-03-12 FR FR143389A patent/FR8046M/fr not_active Expired
- 1968-03-12 NO NO94668A patent/NO123459B/no unknown
- 1968-03-13 NL NL6803570A patent/NL6803570A/xx unknown
- 1968-03-13 BE BE712114D patent/BE712114A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1216523A (en) | 1970-12-23 |
| FR8046M (cg-RX-API-DMAC10.html) | 1970-08-10 |
| NO123459B (cg-RX-API-DMAC10.html) | 1971-11-22 |
| IL29571A (en) | 1972-04-27 |
| DE1720007A1 (de) | 1971-05-19 |
| AT292707B (de) | 1971-09-10 |
| NL6803570A (cg-RX-API-DMAC10.html) | 1968-09-16 |
| SE364277B (cg-RX-API-DMAC10.html) | 1974-02-18 |
| BE712114A (cg-RX-API-DMAC10.html) | 1968-09-13 |
| AT292718B (de) | 1971-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT249071B (de) | Verfahren zur Herstellung basischer Dibenzo-[b,e]-oxepin- bzw. -thiepin-Derivate und ihrer Salze | |
| CH481937A (de) | Verfahren zur Herstellung von neuen in 10-Stellung substituierten Dibenz(b,f)(1,4)oxazepin-11(10H)-onen | |
| AT292718B (de) | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon | |
| AT250975B (de) | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b, f][1, 4] oxazepine | |
| AT292719B (de) | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon | |
| AT292721B (de) | Verfahren zur herstellung neuer 11-basisch substituierter dibenz<b,f>-1,4-oxazepine, dibenzo<b,f>-1,4-thiazepine und dibenzo<b,e>-1,4-diazepine sowie von saeure-additionssalzen davon | |
| AT271901B (de) | Verfahren zur Herstellung von lichtbogen- und kriechstrombeständigen Kunstharzmassen | |
| CH491907A (de) | Verfahren zur Herstellung neuer Aminoalkyl-Derivate des 6,11-Dihydro-dibenzo(b,e)-oxepins bzw. -thiepins und ihrer Salze | |
| AT262259B (de) | Verfahren zur Herstellung neuer Styryläthanolamine und ihrer Salze | |
| AT279631B (de) | Verfahren zur herstellung von neuen 10,11-dihydrodibenzo<b,f>-azepinderivaten sowie von deren saeureadditionssalzen und quaternaeren ammoniumverbindungen | |
| AT278817B (de) | Verfahren zur herstellung neuer 11-aminoalkylierter dibenz <b,f>-1,4-oxazepine und dibenzo <b,f>-1,4-thiazepine sowie von saeure-additionssalzen davon | |
| CH517759A (de) | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,e)-1,4-diazepine | |
| CH467789A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
| ATA233975A (de) | Verfahren zur herstellung neuer 5-amino-7- phenyl-2,3-dihydro-1h-1,4-diazepine | |
| AT283371B (de) | Verfahren zur Herstellung von 1,3,4,5-Tetrahydro-1,4-benzodiazepinderivaten | |
| CH507034A (de) | Maschine zur Herstellung von rohrförmigen Bewehrungskörben | |
| CH517770A (de) | Verfahren zur Herstellung neuer Dibenz(b,f)(1,4)oxazepin-Derivate | |
| AT252926B (de) | Verfahren zur Herstellung neuer 11-basisch substituierter Dibenz[b,f][1,4]oxazepine | |
| AT277258B (de) | Verfahren zur herstellung von neuen dibenzo<b,f>thiepinderivaten sowie von deren saeureadditionssalzen und quaternaeren ammoniumverbindungen | |
| CH467800A (de) | Verfahren zur Herstellung neuer Diazepin-Derivate | |
| AT304489B (de) | Verfahren zur Herstellung von neuen 9-Aminoalkyl-9,10-dihydro-9,10-äthano-anthrazenen und ihren Salzen | |
| AT244980B (de) | Verfahren zur Herstellung neuer basischer Dibenzo-[b,e]-oxepin- bzw. -thiepin-Derivate und ihrer Salze | |
| CH474535A (de) | Verfahren zur Herstellung neuer Oxazepine | |
| CH498222A (de) | Verfahren zur Herstellung von Schlauchgewirken mit laufmaschensicherer Kante | |
| CH474528A (de) | Verfahren zur Herstellung von 1-Methyl-7-halogen-2, 3-dihydro-5-phenyl-1,4-benzodiazepinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |